Endothelium: The main actor in the remodelling of the retinal microvasculature in diabetes

Diabetologia

Volumn 39, Issue 6, 1996, Pages 739-744

  Porta, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVIEW;

EID: 0029970972     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00418548     Document Type: Review

References (65)

1. Gibbons GH, Dzau VJ (1994) The emerging concept of vascular remodelling. N Engl J Med 330: 1431-1437
2. Kohner EM, Hamilton AM, Saunders SJ, Sutcliffe BA, Bulpitt CJ (1975) The retinal blood flow in diabetes. Diabetologia 11: 27-33
3. Grunwald JE, Riva CE, Baine J, Brucker AJ (1992) Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 33: 356-363
4. Atherton A, Hill DW, Keen H, Young S, Edwards EJ (1980) The effect of acute hyperglycaemia on the retinal circulation of the normal cat. Diabetologia 18: 233-237
5. Cooke JP, Rossitch E, Andon NA, Loscalzo J, Dzau VJ (1991) Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 88: 1663-1671
6. Kuchan MJ, Frangos JA (1993) Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 264:H150-H156
7. Frangos JA, Eskin SG, McIntyre LV, Ives CL (1985) Flow effects on prostacyclin production by cultured human endothelial cells. Science 227: 1477-1479
8. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR (1990) Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306-310
9. Kawamura M, Naruse K, Ohgawara H et al. (1992) Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 15: 1396-1397
10. Bertello P, Molino P, Veglio F et al. (1994) Plasma endothelin in NIDDM patients with and without complications. Diabetes Care 17: 574-577
11. Dollery CT, Friedman LA, Hensby CN et al. (1979) Circulating prostacyclin may be reduced in diabetes. Lancet II: 1365
12. 2 release in normal and diabetic rats by the antithrombotic compound Bay G 6375. Thromb Res 19: 663-670
13. Alessandrini P, McRae J, Feman S, FitzGerald GA (1988) Thromboxane biosynthesis and platelet function in type diabetes mellitus. N Engl J Med 319: 208-212
14. Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87: 1643-1648
15. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T (1993) Endothelium-dependent vascular relaxation in patients with type I diabetes mellitus. Diabetes 42: 148-153
16. deTejada JS, Goldstein I, Adadzoi K, Krane RJ, Cohen RA (1993) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Eng J Med 320: 1025-1030
17. McVeigh GE, Brennan GM, Johnson GD (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776
18. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving H-H (1982) Kidney function and size in diabetics, before and during initial insulin treatment. Kidney Int 21: 683-688
19. Paulsen EP, Pauly FL, Croft BY, Teates CD (1990) Simultaneous measurement of glomerular filtration rate and effective renal plasma flow reveals increased glomerular capillary pressure among teenage diabetic subjects. Contrib Nephrol 79: 52-57
20. Keen H, Chlouverakis C (1965) Metabolic factors in diabetic retinopathy. In: Graymore CN (ed) Biochemistry of the retina. Academic Press, London, pp 123-138
21. Williamson JR, Chang K, Frangos M et al. (1993) Hyperglycaemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813
22. Sandeman DD, Shore AC, Tooke JE (1992) Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. New Engl J Med 327: 760-764
23. Harder DR (1987) Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res 60: 102-107
24. Tozzi CA, Pojani GJ, Haranzogo AM, Boyd CD, Riley DJ (1989) Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J Clin Invest 84: 1005-1012
25. Jackson CI, Schwartz SM (1992) Pharmacology of smooth muscle cell replication. Hypertension 20: 713-736
26. Itoh H, Pratt RE, Dzau VJ (1990) Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86: 1690-1697
27. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777
28. Kilo C, Vogler N, Williamson JR (1972) Muscle capillary basement membrane changes related to aging and to diabetes mellitus. Diabetes 21: 881-905
29. Cagliero E, Roth T, Roy S, Lorenzi M (1991) Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 40: 102-110
30. Spiro MJ, HeQ, D'Autilia ML (1995) Effect of high glucose on formation of extracellular matrix components by cultured rat heart endothelial cells. Diabetologia 38: 430-436
31. Rosenblit PD, Metzger RP, Wick AN (1974) Effect of streptozotocin diabetes on acid phosphatase and selected glycosydase activities of serum and various rat organs. Proc Soc Exp Biol Med 145: 244-248
32. Belfiore F, Rabuazzo AM, Iannello S, Campione R, Vasta D (1985) Cathepsin D and other hydrolases in the kidney of streptozotocin-diabetic mice. Possible relevance to microangiopathy. Horm Metabol Res 17: 435-437
33. Wolinsky H, Goldfischer S, Capron L, Capron F, Coltoff-Schiller B, Lasak L (1978) Hydrolase activities in the rat aorta. I. Effects of diabetes and insulin treatment. Circ Res 42: 821-831
34. Juhan-Vague I, Alessi MC, Vague P (1991) Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457-462
35. Wasty F, Alawi MZ, Moore S (1994) Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 36: 316-322
36. Tamsma TT, van den Born J, Bruijn JA et al. (1994) Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320
37. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1992) Receptor specific increase in extracellular matrix production in mouse mesangial cells by advanced glycation end products is mediated via platelet derived growth factor. Proc Natl Acad Sci USA 89: 2873-2877
38. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321
39. Esposito C, Gerlach H, Drett J, Stern D, Vlassara H (1992) Endothelial receptor-mediated binding of glucose modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387-1407
40. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438
41. Kuwabara T, Cogan DG (1963) Retinal vascular patterns. VI. Mural cells of retinal capillaries. Arch Ophthalmol 69: 492-502
42. Porta M, Molinatti PA, Dosso AA, Williams FMK, Brooks RA, Kohner EM (1994) Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabète et Métabolisme 20: 25-30
43. Li W, Shen S, Khatami M, Rockey JH (1984) Stimulation of retinal capillary pericyte protein and collagen synthesis in culture by high-glucose concentration. Diabetes 33: 785-789
44. Williams FMK, Dosso AA, Kohner EM, Porta M (1993) Pericyte growth-promoting activity is reduced in the blood of type 1 diabetic patients with and without retinopathy. Acta Diabetol 30: 123-127
45. Kohner EM, Porta M, Hyer SL (1991) The pathogenesis of diabetic retinopathy and cataract. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell, Oxford, pp 564-574
46. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA (1989) An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci 86: 4544-4548
47. Kohner EM, Henkind P (1970) Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 69: 403-414
48. Fox KA, Saffitz JE, Corr PB (1987) Pathophysiology of myocardial reperfusion. Cardiol Clin 5: 31-48
49. Roy RS, McCord JM (1983) Superoxide and ischemia: conversion of xantine dehydrogenase to xantine oxidase. In: Greenvald R, Cohen G (eds) Oxy radicals and their scavenger systems. Elsevier Science Publishing, New York, pp. 145-153
50. Fasching P, Rohac M, Schneider B, Wagner O, Waldhausl W (1994) Elevation of circulating adhesion molecules in diabetes mellitus type I and II. A new mechanism for diabetic micro- and macroangiopathy. Diabetologia 37 [Suppl 1]:A25 (Abstract)
51. Olson JA, Whitelaw CM, McHardy KC, Pearson DWM, Forrester JV (1994) Endothelial adhesion molecules for leukocytes are elevated in diabetic retinopathy. Diabetologia 37[Suppl 1]:A36 (Abstract)
52. Ware JA, Heistad DD (1993) Platelet-endothelium interactions. N Engl J Med 328: 628-635
53. Ceriello A (1993) Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36: 1119-1125
54. La Selva M, Beltramo E, Passera P, Porta M, Molinatti GM (1993) The role of endothelium in the pathogenesis of diabetic microangiopathy. Acta Diabetol 30: 190-200
55. The DAMAD Study Group (1989) Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicentre randomized controlled clinical trial. Diabetes 38: 491-498
56. The TIMAD Study Group (1990) Ticlopidine treatment reduces the progression of non-proliferative diabetic retinopathy. Arch Ophthalmol 108: 1577-1583
57. Early Treatment of Diabetic Retinopathy Study Group (1991) Effects of aspirin treatment of diabetic retinopathy. ETDRS Report No. 8. Ophthalmology 98: 757-765
58. Ho PC (1979) Proliferative retinopathy in patients with defects of platelet function. Am J Ophthalmol 88: 37-39
59. Valdorf-Hansen F, Hoyer I, Larsen HW (1964) Long-term anticoagulant therapy in diabetic retinopathy. Acta Ophthalmol 42: 579-587
60. Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate JW (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323: 1512-1516
61. Jones EW, Mitchell JRA (1983) Venous thrombosis in diabetes mellitus. Diabetologia 25: 502-505
62. Forrester JV (1987) Mechanisms of new vessel formation in the retina. Diab Med 4: 423-430
63. Aiello LP, Avery RL, Arrigg PG et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487
64. Sivalingham A, Kenney J, Brown CG, Benson WE, Donoso L (1990) Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108: 869-872
65. Grant R, Russel C, Fitzgerald C, Merimee TJ (1986) Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes 35: 416-420